Amid the seasonal surge in virus transmission, products from SHANGHAIHXRT MD Co., Ltd. are experiencing a significant sales boom
As global warming continues, seasonal infectious diseases such as dengue fever, malaria, and hepatitis A have entered a period of high incidence. According to data from the World Health Organization (WHO), global new cases in the first quarter of 2025 increased by 18% compared to the same period last year, driving a surge in demand for rapid virus detection and prevention. Against this backdrop, SHANGHAIHXRT MD CO., LTD, a leading Chinese biotechnology enterprise, has emerged as a reliable partner for public health systems worldwide with its innovative rapid testing products and high-performance laboratory consumables.
Rapid Testing Products: Efficient, Precise, and Multi-Disease Coverage
SHANGHAIHXRT MD’s rapid testing series focuses on "speed, accuracy, and convenience," covering over a dozen seasonal infectious diseases, including dengue, malaria, hepatitis A, and influenza. Leveraging immunochromatographic technology, these tests deliver results within 15 minutes with a 99.2% accuracy rate, significantly reducing diagnosis time and securing critical moments for clinical treatment and epidemic control. To date, the products have been exported to over 50 countries in Southeast Asia, Africa, South America, and other regions, serving more than 20 million testing instances.
Laboratory Consumables: Balancing Quality and Cost-Effectiveness
Beyond rapid testing, SHANGHAIHXRT MD excels in basic laboratory equipment. Its consumables—such as cell culture dishes, slides, and pipette tips—are made from medical-grade high-purity polystyrene, ensuring stable and reproducible experimental data. Notably, through large-scale production and supply chain optimization, the company has drastically reduced costs for research and medical institutions while maintaining quality, winning favor from global clients.
Global Recognition: Technological Innovation Safeguarding Public Health
"Rapid response is key to combating viral mutations and transmission risks," stated Dr. Li, Chief Technology Officer of SHANGHAIHXRT MD. "Our rapid testing products are already widely used in hospitals globally, and our laboratory consumables support virus research at top-tier institutions. Going forward, we will continue investing in R&D to promote accessible infectious disease 防控 technologies."
About SHANGHAIHXRT MD CO., LTD
SHANGHAIHXRT MD is an international enterprise specializing in in vitro diagnostic reagents, laboratory consumables, and biotechnology solutions. Committed to advancing efficient and reliable products for infectious disease 防控，disease diagnosis, and life science research through technological innovation and global collaboration, the company is headquartered in Shanghai with operations spanning over 100 countries and regions.
Post time: Mar-07-2025